Newsletter | June 20, 2025

06.20.25 -- How Is The Market Responding To Brisk HPAPI Demand?

SPONSOR

Enabling Subcutaneous Delivery For Improved Patient Compliance

The ability to administer high doses of biologics subcutaneously offers numerous benefits, including reduced treatment burden, improved patient convenience, and increased adherence to treatment regimens. Discover how Nanoform Biologics’ innovative approach to high-dose subcutaneous delivery of biologics addresses the challenges of traditional SC delivery methods.

INDUSTRY INSIGHTS

How To Establish Effective, Scalable Drug Safety Ops Across Vendors

Numerous factors impact a drug safety program, but proper management of three key elements drives success while creating a scalable drug safety model.

The Role Of Micronization With Dry Powder Inhaler Technologies

Achieving high performance with conventional jet mills remains very difficult. Read about a new generation of spiral jet mills meeting specific particle size distribution targets that have been developed.

Environmental Monitoring Handbook For Pharmaceutical Manufacturers

Acquire a thorough understanding of environmental monitoring, covering the fundamentals of particle counting and cleanroom designs, regulatory expectations regarding market release, and more.

Optimizing TFF And SPTFF For High-Concentration mAb Formulations

Discover the critical role of formulation buffer composition in stabilizing monoclonal antibodies during tangential flow filtration, a process involving ultrafiltration and diafiltration under high pressure.

An Overview Of Blow/Fill/Seal Technology And Its Acceptance By The FDA

The BFS process is the consolidation of an automated form, fill, and seal packaging sequence into one machine. Plastic containers are blow-molded, filled with liquid product, and sealed in one operation.

Nasal Vaccine Development, Manufacturing, And Device Selection

When developing a nasal delivery program, a partner with experience in development and manufacturing techniques who can see a program through clinical to commercial is crucial.

How Oral GLP-1 Therapies Are Revolutionizing Obesity Treatment

The rising incidence and severity of obesity have amplified a therapeutic need in healthcare. Learn more about the challenges and impact of GLP-1 analogs with Dr. Srinivasan Shanmugam.

Utilizing Nanoparticle Technologies For A More Sustainable Value Chain

The pharma industry is identifying ways to make processes more sustainable. Find out how nanoparticle engineering technology can both empower sustainability goals and lead to better patient outcomes.

Container Selection For A Highly Sensitive Drug Product: A Success Story

Explore the importance of selecting the right container for sensitive drug products and how close collaboration is crucial for avoiding commercialization delays and safety risks to patients.

Accelerated Tox Offerings: A Recipe For Streamlining IND Applications

Accelerating the timeline to tox material can significantly enhance the drug development process, enabling faster IND submissions and providing crucial time savings for toxicology studies.

How A Global Pharma Manufacturer Reduced Line Stops And Increased OEE

Gain insight into how a leading pharmaceutical company identified the root cause of long-standing inefficiencies, optimized performance, and productivity with unprecedented speed and accuracy.

Driving Innovation In Decentralized Manufacturing

Unlock the potential of localized manufacturing and see how cutting-edge technology is transforming access to essential medications, ensuring patients get what they need.

Leveraging A Trusted Partner For Outsourcing Stability Storage

Examine the benefits of outsourcing stability storage compared to handling in-house. By outsourcing stability storage, you eliminate the need for investing in and maintaining in-house stability chambers.

SPONSOR

ChemOutsourcing 2025 is the leading U.S. conference for small molecule API, peptide, oligonucleotide, and drug development services. Held September 2–5 in Parsippany, NJ, it attracts biotech and pharma buyers seeking CDMO partners. With 100+ global CDMOs, expert panels, and targeted networking, it’s the go-to event for small molecule, peptide, and oligo outsourcing, connecting innovators across the global pharmaceutical supply chain.

FEATURED EDITORIAL

How Is The Market Responding To Brisk HPAPI Demand?

The rise of precision medicine like ADCs has created new markets for highly potent API. More suppliers are building out capacity to meet the demand.

SOLUTIONS

Biosafety Testing

Batch Execution Module

Making The Complex, Simple

Quality Management And Compliance Consulting

Pharmaceutical Commissioning And Qualification Services

Purpose-Built For The Modern Quality Management Ecosystem

A Leading Digital Validation Platform For Life Sciences

Connect With Pharmaceutical Online: